Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential

被引：13
|
作者：
Esquivel-Ruiz, Sergio [1 ,2 ]
Gonzalez-Rodriguez, Paloma [2 ,3 ]
Lorente, Jose A. [2 ,3 ,4 ]
Perez-Vizcaino, Francisco [1 ,2 ]
Herrero, Raquel [2 ,3 ]
Moreno, Laura [1 ,2 ]
机构：
[1] Univ Complutense Madrid, Sch Med, Inst Invest Sanit Gregorio Maranon IiSGM, Dept Pharmacol & Toxicol, Madrid, Spain
[2] Ciber Enfermedades Resp CIBERES, Madrid, Spain
[3] Hosp Univ Getafe, Dept Crit Care, Madrid, Spain
[4] European Univ Madrid, Sch Med, Clin Sect, Madrid, Spain
来源：
FRONTIERS IN PHYSIOLOGY | 2021年 / 12卷
关键词：
barrier dysfunction; airway epithelium; pulmonary endothelium; mesenchymal stem cells; extracellular vesicles (EVs); preconditioning; MESENCHYMAL STEM-CELLS; ACUTE LUNG INJURY; TISSUE FACTOR ACTIVITY; DISSEMINATED INTRAVASCULAR COAGULATION; NF-KAPPA-B; STROMAL CELLS; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; FLUID CLEARANCE; IN-VITRO;
D O I：
10.3389/fphys.2021.752287
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
Extracellular vesicles (EVs) mediate intercellular communication by transferring genetic material, proteins and organelles between different cells types in both health and disease. Recent evidence suggests that these vesicles, more than simply diagnostic markers, are key mediators of the pathophysiology of acute respiratory distress syndrome (ARDS) and other lung diseases. In this review, we will discuss the contribution of EVs released by pulmonary structural cells (alveolar epithelial and endothelial cells) and immune cells in these diseases, with particular attention to their ability to modulate inflammation and alveolar-capillary barrier disruption, a hallmark of ARDS. EVs also offer a unique opportunity to develop new therapeutics for the treatment of ARDS. Evidences supporting the ability of stem cell-derived EVs to attenuate the lung injury and ongoing strategies to improve their therapeutic potential are also discussed.
引用
收藏
页数：28
相关论文
共 50 条
  • [1] Acute respiratory distress syndrome and the alveolar epithelial barrier (ARDS)
    Posadas-Calleja, JG
    Ugarte-Torres, A
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2003, 55 (04): : 465 - 470
  • [2] Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis
    do Nascimento, Marcelo Fernando
    Ferreira, Ludmila Rodrigues Pinto
    Vieira Junior, Jose Mauro
    Deheinzelin, Daniel
    Nussbaum, Ana Claudia Aparecida Santos
    Sakamoto, Luis Henrique Toshihiro
    Vasconcelos, Renata Ottes
    Salomao, Reinaldo
    Waisberg, Jaques
    Azevedo, Luciano Cesar Pontes
    Chammas, Roger
    Real, Juliana Monte
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [3] Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome
    Li, Jun
    Qi, Zhijiang
    Li, Dongxiao
    Huang, Xiao
    Qi, Boyang
    Feng, Jiali
    Qu, Jianyu
    Wang, Xiaozhi
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [4] Transfer of mitochondria through msc-derived extracellular vesicles improves alveolar-capillary barrier integrity and alleviate mitochondrial dysfunction in acute respiratory distress syndrome (ards)
    Silva, J. D.
    Su, Y.
    McAuley, D.
    O'Kane, C.
    Krasnodembskaya, A.
    CYTOTHERAPY, 2020, 22 (05) : S25 - S25
  • [5] Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome
    Jing, Wenqiang
    Wang, Huijuan
    Zhan, Liying
    Yan, Wei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [6] Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome
    Mahida, Rahul Y.
    Matsumoto, Shotaro
    Matthay, Michael A.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2020, 63 (01) : 15 - 24
  • [7] Simvastatin as a Potential Therapeutic for Acute Respiratory Distress Syndrome
    Shyamsundar, Murali
    O'Kane, C. M.
    McAuley, Daniel F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (10) : 1031 - 1032
  • [8] Alveolar Type 2 Epithelial Cells as Potential Therapeutics for Acute Lung Injury/Acute Respiratory Distress Syndrome
    Zhang, Honglei
    Cui, Yong
    Zhou, Zhiyu
    Ding, Yan
    Nie, Hongguang
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (46) : 4877 - 4882
  • [9] Role of Lipopolysaccharides in the Inflammation and Pyroptosis of Alveolar Epithelial Cells in Acute Lung Injury and Acute Respiratory Distress Syndrome
    Shen, Xiao
    He, Linglin
    Cai, Wanru
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5855 - 5869
  • [10] Breakdown of Epithelial Barrier Integrity and Overdrive Activation of Alveolar Epithelial Cells in the Pathogenesis of Acute Respiratory Distress Syndrome and Lung Fibrosis
    Yanagi, Shigehisa
    Tsubouchi, Hironobu
    Miura, Ayako
    Matsumoto, Nobuhiro
    Nakazato, Masamitsu
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
12345